<?xml version="1.0" encoding="UTF-8"?>
<p id="p0100">Based on the historical records and anecdotal evidence of SARS and H
 <sub>1</sub>N
 <sub>1</sub> pdm09 prevention, Chinese herbal drugs were also considered as an alternative approach for prevention of COVID-19 in high-risk populations. However, clinical evidence for these treatments in the prevention of this emerging viral infection is lacking.
 <xref rid="bib57" ref-type="bibr">
  <sup>57</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib58" ref-type="bibr">
  <sup>58</sup>
 </xref> During the COVID-19 outbreak in China, some traditional Chinese medicine was widely used, and the six most commonly used herbal medicines were 
 <italic>Astragali Radix</italic> (Huangqi), 
 <italic>Glycyrrhizae Radix Et Rhizoma</italic> (Gancao), 
 <italic>Saposhnikoviae Radix</italic> (Fangfeng), 
 <italic>Atractylodis Macrocephalae Rhizoma</italic> (Baizhu), 
 <italic>Lonicerae Japonicae Flos</italic> and 
 <italic>Fructus forsythia</italic> (Lianqiao). However, rigorous clinical trials on large populations should be conducted to confirm the potential preventive effect of Chinese medicine.
 <xref rid="bib57" ref-type="bibr">
  <sup>57</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib58" ref-type="bibr">
  <sup>58</sup>
 </xref>
</p>
